| [1] |
WANG Jing, QU Yang, GUO Zhenni, YANG Yi.
Association between Cerebral Autoregulation and Outcomes in Patients with Different Subtypes of Acute Ischemic Stroke Receiving Intravenous Thrombolysis
[J]. Chinese Journal of Stroke, 2026, 21(8): 929-936.
|
| [2] |
CHENG Li, YE Jianing, XU Yuluan, FAN Jinghua, DONG Fang, HAN Xinggui, WU Zongyi, YE Shujun, SI Fuzhong.
Analysis of Incidence Trends and Distribution Characteristics of Acute Ischemic Stroke in Tengzhou City, Shandong Province from 2013 to 2021
[J]. Chinese Journal of Stroke, 2026, 21(8): 986-994.
|
| [3] |
WU Meiyan, ZHANG Fan.
Mechanisms and Clinical Significance of Protein Glycosylation Modification in Acute Ischemic Stroke
[J]. Chinese Journal of Stroke, 2026, 21(8): 1038-1043.
|
| [4] |
WANG Tingting, CHEN Huisheng.
Advances and Prospects in Non-Pharmacological Treatment of Acute Ischemic Stroke: From Mechanisms and Strategies to Evidence
[J]. Chinese Journal of Stroke, 2026, 21(7): 797-803.
|
| [5] |
LI Ying, CUI Yu, LONG Yuxia, GUO Xuanyu, CHEN Huisheng.
Effect of Antidiabetic Drugs on the Outcomes of Remote Ischemic Conditioning in Patients with Diabetes Mellitus Complicated by Acute Ischemic Stroke: A Post-Hoc Analysis of the RICAMIS Trial
[J]. Chinese Journal of Stroke, 2026, 21(7): 805-813.
|
| [6] |
WU Qiong, ZHANG Nannan, ZHANG Yina, CHEN Huisheng.
Association between Responsible Artery Stenosis Rate and Efficacy of Head-Down Position Therapy in Moderate Acute Ischemic Stroke: A Subgroup Analysis of the HOPES 2 Trial
[J]. Chinese Journal of Stroke, 2026, 21(7): 814-822.
|
| [7] |
GAO Dan, CHEN Huisheng.
Effect of Stroke Severity on the Efffcacy of Head-Down Position Therapy in Acute Ischemic Stroke: A Post-Hoc Analysis of the HOPES 2 Trial
[J]. Chinese Journal of Stroke, 2026, 21(7): 823-828.
|
| [8] |
NIU Jingyuan, WU Qiong, CUI Yu, KONG Ying, WANG Tingting, LUO Xin, LI Xiandong, ZHAO Qiankun, WANG Haiyan, CHEN Huisheng.
Electroacupuncture as an Adjuvant Therapy for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled Trials
[J]. Chinese Journal of Stroke, 2026, 21(7): 829-838.
|
| [9] |
LIN Jinxi, LI Shangzhi, ZHANG Yanli, GAO Peiyuan, ZHOU Hongyu.
Impact of Diabetes Duration and Lp-PLA2 Activity on Acute Ischemic Stroke Clinical Outcomes
[J]. Chinese Journal of Stroke, 2026, 21(6): 703-711.
|
| [10] |
CUI Yu, WANG Lu, CHEN Huisheng.
Analysis of Influencing Factors for Good Outcomes in Patients with Acute Ischemic Stroke Receiving Intravenous Thrombolysis with Tenecteplase
[J]. Chinese Journal of Stroke, 2026, 21(6): 712-718.
|
| [11] |
KONG Xianghui, FAN Yani, HAN Dechang, LI Guangmin, LU Yadan, LIU Yulan, CHEN Lili.
Analysis of Prognostic Factors in Elderly Patients with Anterior Circulation Minor Acute Ischemic Stroke
[J]. Chinese Journal of Stroke, 2026, 21(6): 740-745.
|
| [12] |
HE Dandan, LI Jian, WANG Chunjuan, LI Shuya.
Challenges and Breakthroughs in Basic and Clinical Research of Brain Cytoprotective Agents for Acute Ischemic Stroke in China
[J]. Chinese Journal of Stroke, 2026, 21(5): 517-524.
|
| [13] |
CHENG Xiyue, ZHAO Jingyan, WANG Chunjuan.
Research Progress of Edaravone Dexborneol in Brain Cytoprotection for Acute Ischemic Stroke
[J]. Chinese Journal of Stroke, 2026, 21(5): 526-532.
|
| [14] |
YANG Qianqian, ZHANG Meiyang, LU Yao, ZHOU Dongyang, WANG Zhengyilei, Shan Shuyi, LIU Chenhui, WANG Yilong, GUAN Ling.
Research Progress on the Anti-Neuroinflammatory Effects and Brain Cytoprotection of Minocycline in Acute Ischemic Stroke: From Mechanisms to Clinical Evidence
[J]. Chinese Journal of Stroke, 2026, 21(5): 533-542.
|
| [15] |
HE Dandan, LI Shuya.
Research Progress of PSD-95-Targeted Brain Cytoprotective Agents in Acute Ischemic Stroke Based on STAIR Principles
[J]. Chinese Journal of Stroke, 2026, 21(5): 543-552.
|